CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.

Flexible display manufacturer Royole is seeking $1bn in funding as it prepares for an initial public offering that could provide an exit to Yuexiu Group.

Cystic fibrosis drug developer Respirion Pharmaceuticals has spun out from Telethon Kids Institute with capital from an Australian government-backed initiative.

Star India and Star US have injected $153m into Hotstar, a video streaming subsidiary of the former that is set to debut its first slate of original programming this month.

The central nervous system disorder drug developer has now raised more than $118m, with PureTech Health and Pivotal BioVenture Partners among the investors in its latest round.

Goldwind, Legal & General and Equinor have all taken part in the $41m first close of the solar power technology provider's series D round, taking its total equity and debt financing to more than $118m.

Tencent and Meituan Dianping-backed consumer goods trading platform Yijiupi has added $100m from Warburg Pincus to its coffers in a series D-plus round.

The Ola-backed point-of-sale technology developer has received a further $31.5m from some of its existing investors, according to regulatory filings.

Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.

Hearst Health Ventures contributed to a BVP-led round that boosted the health benefits data platform's total funding to about $51m.